Suppr超能文献

孕早期用药后的遗传咨询与产前护理

[Genetic counseling and prenatal care after medications during the first trimester].

作者信息

Horváth E, Faragó M, Keszthelyi G, Keresztúri A, Szabó A, Szemere G, Szabó J

机构信息

Szegedi Tudományegyetem, Altalános Orvostudományi Kar, Szent-Györgyi Albert Orvos- és Gyógyszerésztudományi Centrum, Orvosi Genetikai Intézet.

出版信息

Orv Hetil. 2000 May 28;141(22):1179-83.

Abstract

Analysis of the outcome of 127 pregnancies with first trimester medication (8.4% of the total number of the patients seeking genetic advice in 1997 at the Institute of Medical Genetics in Szeged) was carried out. The gestational age at the time of the medication and genetic counselling, the indications of the treatment, the drugs, the estimated fetal risk, and results of genetic ultrasound examinations and pregnancy outcome were evaluated. The majority of pregnant woman (78%) asked for genetic counselling before the 12. gestational week. The main indications the treatment were: infections, psychiatric-neurologic (depression, anxiety, epilepsy), endocrine (diabetes, hyperthyreoidism), and cardiovascular diseases and gastrointestinal problems. The main groups of the drugs were: antibiotics, antipyretic-, antidepressive-, antidiabetic- and antihypertensive drugs. When the multiple medication was conducted by simultaneous administration of two or more drugs, a complex risk calculation was performed. The fetal risk was higher than 10% in 31 cases (24%). The ultrasound examinations performed by qualified sonographer contributed to a correct evaluation and to reliable follow-up of pregnancies. No suspicious ultrasound finding was reported in the first trimester. However, a severe fatal brain malformation was found in a second trimester pregnancy, which was terminated by the couple's request in the 18th gestational week. A complete follow-up was obtained in 70.9% (90) of the cases. Out of 64 pregnancies intended to continue to term 4 fetal malformations were found. Of them three malformations (patent ductus arteriosus, Robin sequence and a ventricular septal defect) were explored at birth or in the newborn period. The actual 6.3% of fetal malformations was higher compared to the rate expected at birth, but almost equal to the rate of congenital malformation found up to the end of the first year of age in Hungary.

摘要

对127例孕早期用药的妊娠结局进行了分析(占1997年塞格德医学遗传研究所寻求遗传咨询患者总数的8.4%)。评估了用药及遗传咨询时的孕周、治疗指征、药物、估计的胎儿风险、遗传超声检查结果及妊娠结局。大多数孕妇(78%)在妊娠12周前寻求遗传咨询。治疗的主要指征为:感染、精神神经疾病(抑郁症、焦虑症、癫痫)、内分泌疾病(糖尿病、甲状腺功能亢进)、心血管疾病及胃肠道问题。主要药物类别为:抗生素、退热药、抗抑郁药、抗糖尿病药及抗高血压药。当同时服用两种或更多药物进行联合用药时,进行了综合风险计算。31例(24%)胎儿风险高于10%。由合格超声检查医师进行的超声检查有助于对妊娠进行正确评估及可靠随访。孕早期未报告可疑超声检查结果。然而,在孕中期发现一例严重致命脑畸形,该孕妇在妊娠18周时经夫妇要求终止妊娠。70.9%(90例)的病例获得了完整随访。在计划继续妊娠至足月的64例妊娠中,发现4例胎儿畸形。其中3例畸形(动脉导管未闭、罗宾序列征及室间隔缺损)在出生时或新生儿期被发现。实际胎儿畸形率为6.3%,高于预期出生时的发生率,但几乎与匈牙利一岁末时发现的先天性畸形率相等。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验